A response in advanced post-menopausal breast cancer during treatment with the luteinising hormone releasing hormone agonist — Zoladex
- 1 November 1989
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 48 (2) , 123-124
- https://doi.org/10.1016/0304-3835(89)90047-5
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Endocrine and Clinical Effects of an Lhrh Analogue in Pretreated Advanced Breast CancerTumori Journal, 1988
- Remission of postmenopausal breast cancer during treatment with the luteinising hormone releasing hormone agonist ICI 118630British Journal of Cancer, 1986
- The use of an LH-RH agonist (ICI 118630, Zoladex) in advanced premenopausal breast cancerBritish Journal of Cancer, 1986
- Endocrinological and clinical aspects of LHRH action (ICI 118630) in hormone dependent breast cancerJournal of Steroid Biochemistry, 1985
- LHRH-Agonist treatment in clinical and experimental human breast cancerJournal of Steroid Biochemistry, 1985
- Gonadotropin-Releasing Hormone Binding Sites in Human Breast CarcinomaScience, 1985
- Growth of human breast cancer cells inhibited by a luteinizing hormone-releasing hormone agonistNature, 1985
- Chapter 21. Luteinizing Hormone Releasing Hormone (LHRH) AnaloguesPublished by Elsevier ,1985
- LHRH analogs for human mammary carcinomaPublished by Springer Nature ,1984